Who administers Patient Assistance Programs (PAPs)?

Patient Assistance Programs (PAPs) are primarily administered by drug manufacturers. These programs are designed to provide medications at little to no cost to patients who are uninsured or underinsured and cannot afford their prescriptions. The goal of PAPs is to enhance access to necessary medications, particularly for those individuals who may be facing financial hardship.

Drug manufacturers establish PAPs as part of their corporate social responsibility and to ensure that their medications reach those in need. By offering these programs, they can help improve patient adherence to treatment regimens and ultimately enhance health outcomes.

While government agencies, insurance companies, and non-profit organizations may have their own programs to assist patients in accessing medications or funding for health care, the specific focus of PAPs is concentrated in the hands of drug manufacturers who provide these services directly related to their own products. This distinction clarifies why manufacturers play a crucial role in administering Patient Assistance Programs.